… who were undergoing an antiplatelet therapy with aspirin 100 mg … In thrombosis prophylaxis,
the new substances (Apixaban, … Using exome sequencing, we defined mutations present in …

… However, experts do use early anticoagulation therapy for … ) like dabigatran, rivaroxaban,
apixaban, and edoxaban provide … Sanad II study (2021), an open-label, randomized controlled …

… She was continued on dual antiplatelet therapy (DAPT) with … Statins, aspirin, enoxaparin,
and rivaroxaban/apixaban have … trial, a phase 3, randomized, open-label study, no patients …

… trial, an open label active treatment extension was performed … A 1 year prospective-descriptive
study on consecutive … and function in vitro and vivo, illuminating epigenetic targets …

… the necessary pentasaccharide sequence to bind to … antiplatelet therapy in the context of
acute coronary disease. The APRAISE-2 study randomly assigned 7,392 patients to apixaban (…

… of 2 trials comparing triple antiplatelet therapy with dual antiplatelet therapy in patients at …
in CPVT models in vitro (144). The investigators collected data from 33 consecutive genotype-…

… center study; and safety and efficacy of long-term open-label … and venous thrombosis in
consecutive hospitalized cirrhotic … in-vivo-like ex ovo hen's egg model of thrombosis, where 4-…

… Methods: Multi-national, open-label, dose-escalating study in … Methods: The study population
comprised 646 consecutive … and apixaban subgroups can be explained by the effect of …

… and Sabraud's dextrose fluid were put into the chambers. … induce thrombus and
thrombocytopenia in in-vivo models. … fondaparinux, apixaban, or rivaroxaban may be used. …

… promote research to deepen the understanding of ozone therapy. … We suggest that two or
more oxidative therapies should not … the dose in each consecutive cycle, repeated at a 3 to 4-…